The Application Effect of Modified Pressure-Reducing Fixation Protective Nasal Strip in the Nursing Care of Patients Receiving High-Flow Nasal Cannula Therapy (HFNC; pressure)

Ying Zhou

Status: Completed

Conditions: High-Flow Nasal Cannula Therapy

Treatments: Device: the modified pressure-reducing fixation protective nasal strip; Device: Standard care alone

Study type: Interventional

Funder types: Other

Identifiers

NCT06720129

KS2024035

Details and patient eligibility

About

This study was a prospective, randomized controlled trial that included 60 patients receiving high-flow nasal cannula (HFNC) therapy. Participants were randomly divided into two groups: the observation group (n=30), which used a modified decompression fixation protective patch, and the control group (n=30), which received hydrocolloid dressing protection in addition to standard care. The study compared general demographic data, the interval time between changing fixation straps, the times of adjusting the catheter position, the effectiveness of skin management, the number of ineffective oxygenation attempts, the incidence of adverse events, and patient comfort scores between the two groups.

Enrollment: 60 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1. Meet the diagnostic criteria for respiratory failure, worsening dyspnea, acute exacerbation of chronic obstructive pulmonary disease (COPD), bronchitis, pneumonia, and congestive heart failure.
• 2. No severe cognitive impairment.
• 3. Good compliance and being able to actively cooperate with the investigation.
• 4. No concurrent metabolic diseases.

Exclusion criteria

• 1. Patients with severe respiratory failure, severe arrhythmias, concurrent pneumothorax, coma upon admission, or persistent vomiting.
• 2. Patients with severe liver failure, kidney failure, or other severe systemic diseases.
• 3. Patients with severe cognitive impairment who are unable to understand or comply with the study requirements.
• 4. Patients with severe hemodynamic instability.
• 5. Patients with allergies to oxygen therapy or protective patch materials.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

60 participants in 2 patient groups

The control group

Other group

Description:

The control group received standard care plus a hydrocolloid dressing for protection

Treatment:

Device: Standard care alone

The observation group

Other group

Description:

The observation group employed the modified pressure-reducing fixation protective nasal strip

Treatment:

Device: the modified pressure-reducing fixation protective nasal strip